HFA
PFE icon

Harbert Fund Advisors’s Pfizer PFE Stock Holding History

Harbert Fund Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$6.12M Buy
218,178
+7,378
+4% +$207K 7.08% 6
2014
Q2 		$5.94M Buy
+210,800
New +$6.01M 6.87% 4

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harbert Fund Advisors's PFE Position: Q3 2014 in Review

Harbert Fund Advisors increased its Pfizer (PFE) stake by 3.5% in Q3 2014, buying an estimated $207K and bringing the position to 218,178 shares worth $6.12M. The position accounts for 7.08% of the portfolio, ranked #6.

Harbert Fund Advisors first reported a position in PFE in Q2 2014 and has held it in 2 quarters since. 1,742 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • Harbert Fund Advisors held 218,178 shares of Pfizer worth $6.12M as of Q3 2014.
  • Harbert Fund Advisors bought 7,378 Pfizer shares in Q3 2014, an estimated $207K.
  • Pfizer made up 7.08% of Harbert Fund Advisors's portfolio in Q3 2014, its #6 holding.
  • Harbert Fund Advisors first reported a position in Pfizer in Q2 2014 and has held it in 2 quarters since.
  • 1,742 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Harbert Fund Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.